BioCentury
ARTICLE | Financial News

GW raises $276M in follow-on

December 8, 2017 4:08 AM UTC

GW Pharmaceuticals plc (NASDAQ:GWPH) raised $276 million through the sale of 2.4 million ADSs at $115 in a bumped-up follow-on underwritten by Goldman Sachs, Morgan Stanley, BofA Merrill Lynch and Cowen. The price is a 4% discount to GW's close of $119.41 on Tuesday, when it proposed after market hours to raise $225 million. Each ADS represents 12 ordinary shares...

BCIQ Company Profiles

GW Pharmaceuticals plc

BCIQ Target Profiles

Cannabinoid receptors